Avenue Therapeutics, Inc. (ATXI)
NASDAQ: ATXI · Real-Time Price · USD
2.010
+0.030 (1.52%)
Nov 21, 2024, 4:00 PM EST - Market closed
Avenue Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -9.41 | -10.38 | -3.55 | -3.73 | -5.15 | -25.91 | |
| Asset Writedown & Restructuring Costs | - | 3 | - | - | - | - | |
| Stock-Based Compensation | 1.02 | 0.91 | 0.65 | 0.44 | 0.71 | 1.84 | |
| Other Operating Activities | -1.66 | -2.69 | -5.1 | - | - | - | |
| Change in Accounts Receivable | 0.01 | - | 0.09 | -0.09 | - | - | |
| Change in Accounts Payable | -0.78 | -0.36 | 0.35 | -0.38 | -0.23 | -3.23 | |
| Change in Other Net Operating Assets | 0.23 | 0.07 | -0.03 | 0.01 | 0.06 | 1.04 | |
| Operating Cash Flow | -10.59 | -9.45 | -7.6 | -3.75 | -4.61 | -26.26 | |
| Sale (Purchase) of Intangibles | - | -3 | - | - | - | - | |
| Other Investing Activities | - | - | - | - | -1 | - | |
| Investing Cash Flow | - | -3 | - | - | -1 | - | |
| Issuance of Common Stock | 14.16 | 7.53 | 11.65 | 5.04 | - | 35 | |
| Repurchase of Common Stock | - | - | -1.1 | - | - | - | |
| Other Financing Activities | -1.14 | - | - | -0.66 | - | -2.67 | |
| Financing Cash Flow | 13.02 | 7.53 | 10.54 | 4.38 | - | 32.33 | |
| Net Cash Flow | 2.44 | -4.93 | 2.95 | 0.63 | -5.61 | 6.07 | |
| Free Cash Flow | -10.59 | -9.45 | -7.6 | -3.75 | -4.61 | -26.26 | |
| Free Cash Flow Per Share | -11.88 | -66.92 | -260.72 | -248.20 | -314.41 | -1879.00 | |
| Levered Free Cash Flow | -10.21 | -13.49 | -1.25 | -2.36 | -3.72 | -15.93 | |
| Unlevered Free Cash Flow | -10.21 | -13.49 | -1.25 | -2.36 | -3.72 | -15.93 | |
| Change in Net Working Capital | 3.74 | 2.31 | -3.13 | 0.46 | 1.17 | 1.36 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.